APO Research
Talk to an analyst

APO RESEARCH · REPORT

Component DTP Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Component DTP Vaccine Industry Growth and Trends Forecast to 2032

28 December 202597 pages

Choose your research edition.

Industry ResearchComponent DTP Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Component DTP Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Component DTP Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Component DTP Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Component DTP Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Component DTP Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Component DTP Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Component DTP Vaccine include GSK, Sanofi, Hualan Biological Vaccine, BioKangtai, CanSino Biologics, Walvax Biotechnology and CNBG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Component DTP Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Component DTP Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Component DTP Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Component DTP Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Component DTP Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Component DTP Vaccine Market by Company

GSK

Sanofi

Hualan Biological Vaccine

BioKangtai

CanSino Biologics

Walvax Biotechnology

CNBG

Component DTP Vaccine Segment by Type

Five Components

Three Components

Two Components

Component DTP Vaccine Segment by Application

Adults

Children

Component DTP Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Component DTP Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Component DTP Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Component DTP Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Component DTP Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Component DTP Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Five Components Table 2. Major Company of Three Components Table 3. Major Company of Two Components Table 4. Global Component DTP Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Component DTP Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Component DTP Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Component DTP Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Component DTP Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Component DTP Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Component DTP Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Component DTP Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Component DTP Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Component DTP Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Component DTP Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Component DTP Vaccine Industry Trends Table 26. Component DTP Vaccine Industry Drivers Table 27. Component DTP Vaccine Industry Opportunities and Challenges Table 28. Component DTP Vaccine Industry Restraints Table 29. Global Component DTP Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Component DTP Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Component DTP Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Component DTP Vaccine Sales Share by Company (2021-2026) Table 33. Global Component DTP Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Component DTP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Component DTP Vaccine Major Company Production Sites and Headquarters Table 36. Global Component DTP Vaccine Company, Product Type & Application Table 37. Global Component DTP Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Component DTP Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Component DTP Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Component DTP Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Component DTP Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Component DTP Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Component DTP Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Component DTP Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Component DTP Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Component DTP Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Component DTP Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Component DTP Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Component DTP Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Component DTP Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Component DTP Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Component DTP Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Component DTP Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Component DTP Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Component DTP Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Component DTP Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Component DTP Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Component DTP Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Component DTP Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GSK Component DTP Vaccine Product Portfolio Table 76. GSK Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Component DTP Vaccine Product Portfolio Table 81. Sanofi Recent Development Table 82. Hualan Biological Vaccine Company Information Table 83. Hualan Biological Vaccine Business Overview Table 84. Hualan Biological Vaccine Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hualan Biological Vaccine Component DTP Vaccine Product Portfolio Table 86. Hualan Biological Vaccine Recent Development Table 87. BioKangtai Company Information Table 88. BioKangtai Business Overview Table 89. BioKangtai Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. BioKangtai Component DTP Vaccine Product Portfolio Table 91. BioKangtai Recent Development Table 92. CanSino Biologics Company Information Table 93. CanSino Biologics Business Overview Table 94. CanSino Biologics Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. CanSino Biologics Component DTP Vaccine Product Portfolio Table 96. CanSino Biologics Recent Development Table 97. Walvax Biotechnology Company Information Table 98. Walvax Biotechnology Business Overview Table 99. Walvax Biotechnology Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Walvax Biotechnology Component DTP Vaccine Product Portfolio Table 101. Walvax Biotechnology Recent Development Table 102. CNBG Company Information Table 103. CNBG Business Overview Table 104. CNBG Component DTP Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CNBG Component DTP Vaccine Product Portfolio Table 106. CNBG Recent Development Table 107. North America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 109. North America Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 110. North America Component DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Component DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 112. North America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Component DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Component DTP Vaccine Market Share by Country (2021-2026) Table 115. North America Component DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Component DTP Vaccine Market Share Forecast by Country (2027-2032) Table 117. Europe Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 119. Europe Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 120. Europe Component DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Component DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Component DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Component DTP Vaccine Market Share by Country (2021-2026) Table 125. Europe Component DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Component DTP Vaccine Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Component DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Component DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Component DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Component DTP Vaccine Market Share by Country (2021-2026) Table 135. Asia-Pacific Component DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Component DTP Vaccine Market Share Forecast by Country (2027-2032) Table 137. Latin America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 139. Latin America Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 140. Latin America Component DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Component DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Component DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Component DTP Vaccine Market Share by Country (2021-2026) Table 145. Latin America Component DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Component DTP Vaccine Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Component DTP Vaccine Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Component DTP Vaccine Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Component DTP Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Component DTP Vaccine Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Component DTP Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Component DTP Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Component DTP Vaccine Market Share by Country (2021-2026) Table 155. Middle East and Africa Component DTP Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Component DTP Vaccine Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Component DTP Vaccine Distributors List Table 160. Component DTP Vaccine Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Component DTP Vaccine Image Figure 2. Global Component DTP Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Component DTP Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Component DTP Vaccine Sales (2021-2032) & (K Units) Figure 5. Five Components Image Figure 6. Global Five Components Sales YoY Growth (2021-2032) & (K Units) Figure 7. Three Components Image Figure 8. Global Three Components Sales YoY Growth (2021-2032) & (K Units) Figure 9. Two Components Image Figure 10. Global Two Components Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Component DTP Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Component DTP Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Component DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Component DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Component DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Component DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Component DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Component DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Component DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Component DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Component DTP Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Component DTP Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Component DTP Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Component DTP Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Component DTP Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Component DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Component DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Component DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Component DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Component DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Component DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Component DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Component DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Component DTP Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Component DTP Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Component DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Component DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Component DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Component DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Component DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Component DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Component DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Component DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Component DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Component DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Component DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Component DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Component DTP Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Component DTP Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Component DTP Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Component DTP Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Component DTP Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Component DTP Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Five Components
  • Three Components
  • Two Components
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Sanofi
  • Hualan Biological Vaccine
  • BioKangtai
  • CanSino Biologics
  • Walvax Biotechnology
  • CNBG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Component DTP Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Component DTP Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Component DTP Vaccine Market by Type
  6. 1.3.1 Five Components
  7. 1.3.2 Three Components
  8. 1.3.3 Two Components
  9. 1.4 Global Component DTP Vaccine Market Size by Type
  10. 1.4.1 Global Component DTP Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Component DTP Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Component DTP Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Component DTP Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Component DTP Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Component DTP Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Component DTP Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Component DTP Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Component DTP Vaccine Industry Trends
  2. 2.2 Component DTP Vaccine Industry Drivers
  3. 2.3 Component DTP Vaccine Industry Opportunities and Challenges
  4. 2.4 Component DTP Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Component DTP Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Component DTP Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Component DTP Vaccine Price (2021-2026)
  4. 3.4 Global Component DTP Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Component DTP Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Component DTP Vaccine Company, Product Type & Application
  7. 3.7 Global Component DTP Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Component DTP Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Component DTP Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Component DTP Vaccine Tier 1, Tier 2, and Tier 3
4 Component DTP Vaccine Regional Status and Outlook
  1. 4.1 Global Component DTP Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Component DTP Vaccine Historic Market Size by Region
  3. 4.2.1 Global Component DTP Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Component DTP Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Component DTP Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Component DTP Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Component DTP Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Component DTP Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Component DTP Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Component DTP Vaccine by Application
  1. 5.1 Component DTP Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Component DTP Vaccine Market Size by Application
  5. 5.2.1 Global Component DTP Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Component DTP Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Component DTP Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Component DTP Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Component DTP Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Component DTP Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Component DTP Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Component DTP Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Component DTP Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Component DTP Vaccine Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Hualan Biological Vaccine
  14. 6.3.1 Hualan Biological Vaccine Company Information
  15. 6.3.2 Hualan Biological Vaccine Business Overview
  16. 6.3.3 Hualan Biological Vaccine Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hualan Biological Vaccine Component DTP Vaccine Product Portfolio
  18. 6.3.5 Hualan Biological Vaccine Recent Developments
  19. 6.4 BioKangtai
  20. 6.4.1 BioKangtai Company Information
  21. 6.4.2 BioKangtai Business Overview
  22. 6.4.3 BioKangtai Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioKangtai Component DTP Vaccine Product Portfolio
  24. 6.4.5 BioKangtai Recent Developments
  25. 6.5 CanSino Biologics
  26. 6.5.1 CanSino Biologics Company Information
  27. 6.5.2 CanSino Biologics Business Overview
  28. 6.5.3 CanSino Biologics Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CanSino Biologics Component DTP Vaccine Product Portfolio
  30. 6.5.5 CanSino Biologics Recent Developments
  31. 6.6 Walvax Biotechnology
  32. 6.6.1 Walvax Biotechnology Company Information
  33. 6.6.2 Walvax Biotechnology Business Overview
  34. 6.6.3 Walvax Biotechnology Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Walvax Biotechnology Component DTP Vaccine Product Portfolio
  36. 6.6.5 Walvax Biotechnology Recent Developments
  37. 6.7 CNBG
  38. 6.7.1 CNBG Company Information
  39. 6.7.2 CNBG Business Overview
  40. 6.7.3 CNBG Component DTP Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CNBG Component DTP Vaccine Product Portfolio
  42. 6.7.5 CNBG Recent Developments
7 North America by Country
  1. 7.1 North America Component DTP Vaccine Sales by Country
  2. 7.1.1 North America Component DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Component DTP Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Component DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Component DTP Vaccine Market Size by Country
  6. 7.2.1 North America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Component DTP Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Component DTP Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Component DTP Vaccine Sales by Country
  2. 8.1.1 Europe Component DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Component DTP Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Component DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Component DTP Vaccine Market Size by Country
  6. 8.2.1 Europe Component DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Component DTP Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Component DTP Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Component DTP Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Component DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Component DTP Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Component DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Component DTP Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Component DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Component DTP Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Component DTP Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Component DTP Vaccine Sales by Country
  2. 10.1.1 South America Component DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Component DTP Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Component DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Component DTP Vaccine Market Size by Country
  6. 10.2.1 South America Component DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Component DTP Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Component DTP Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Component DTP Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Component DTP Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Component DTP Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Component DTP Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Component DTP Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Component DTP Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Component DTP Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Component DTP Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Component DTP Vaccine Value Chain Analysis
  2. 12.1.1 Component DTP Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Component DTP Vaccine Production Mode & Process
  7. 12.2 Component DTP Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Component DTP Vaccine Distributors
  10. 12.2.3 Component DTP Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst